Growing Number of Infectious Diseases is Escalating the Demand of PCR Technologies Globally

The global PCR Technologies market is expected to witness a boost owing to the increase in applications of PCR Technologies in varied segments, growing focus on genome research and rising government funding for conducting gene-based research across the world. For instance, in Ireland, Genomics Medicine Ireland (GMI) received funding of USD 413.91 million for conducting genome related research in 2018 enabling scientists to expand their research to over 60 areas of diseases. Furthermore, with the widespread expansion of the coronavirus, there is surge in demand for an effective and accurate molecular diagnostics technique including PCR. Thus, many industry players are launching new and innovative PCR kits for affordable and accurate diagnosis of COVID-19. For example, in 2020, Equine Biotech, IISC startup, has developed an indigenous RT-PCR diagnostic kit called "GlobalTM diagnostic kit“. The test takes about 1.5 hours to confirm the presence of SARS-CoV-2 in patient samples.

Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=9524 ?

Polymerase Chain Reaction (PCR) is widely used to detect the presence of a virus that causes COVID-19 across the globe. As of March 16, 2021, there have been almost 121 million cases of COVID-19 worldwide. The disease has impacted more than 210 countries and territories, with the United States confirming around one-fifth of all global cases. Therefore, it has become imperative to decipher the transmission chain of the virus which in turn will help in controlling the spread of this virus. Owing to these facts, many government agencies and public health institutions have geared up to fight against this virus with the help of sequencing. For instance, Recently, in March 2020, the COVID-19 genomics U.K. consortium (COG-U.K.) was performed to study the coronavirus genome by using whole-genome sequencing.

According to UnivDatos Market Insights (UMI)’ research report “Global PCR Technologies Market Analysis, 2020”, the PCR technologies market is projected to grow at a CAGR of XX% during 2021-27F. A rise in seed funding and series funding is one of the prominent reason which is driving the market of the PCR technologies. For Instance, UgenTec, the medical technology company that has created an AI-driven PCR analysis and workflow software, closed of a $9.3 million series A funding round in march, 2021.

Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=9524 ?

Based on the Application, the clinical diagnostics segment acquired the major market share and grabbed US$ XX Mn revenue from the PCR technologies market in 2020 as PCR technologies are used for diagnosing genetic diseases owing to its ability to detect and quantify low-freqguency mutation and low levels of pathogen with high sensitivity. However, the research segment is also expected to grow at the highest CAGR of XX% during the forecast period.?

Diagnoatic Labs & Hospitals Among End-Users to Witness Robust growth

Based on the end-users, the market is divide into pharma & biotechnology companies, diagnostic labs & hospitals, academic & government research institutes, and others. The diagnostic labs & hospitals grabbed XX% revenue share in 2020. The market size of this segment touched US$ XX Million in 2020. The market share of the segment is expected to maintain its dominance in the forthcoming years as well owing to the growing number of diagnostic & medical labs all over the world. For instance, in 2021, there are 29,227 diagnostic & medical laboratories businesses in the United States, an increase of 2% from 2020. ?

North America to Grab Lion’s Share

Based on the Region, North America dominated the global PCR technologies market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of well-established players such as Thermo Fischer Scientific, Agilent Technologies, Bio-Rad Laboratories, etc. coupled with high product approvals and launches. North America is expected to skyrocket with a CAGR of XX% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global PCR Technologies Market Analysis, 2020”.?

For more informative information, please visit us – https://univdatos.com/report/pcr-technologies-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global PCR technologies market include Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, Takara Bio, Inc., Merck KGaA, BioMerieux SA, Siemens Healthineers, Abbott Laboratories, among others. The players are focused on launching new products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry. Some of the instances are:

§?In 2021, Bio-Rad Laboratories, launched the Reliance SARS-CoV-2/FluA/FluB RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.

§?In 2021, Cipla launched ‘ViraGen’, a polymerase chain reaction (Covid-19 RT-PCR) test for Covid-19 in India. The pharma company also announced the commercialisation of test kit ‘ViraGen’ in partnership with Ubio Biotechnology Systems Pvt. Ltd.?

“Global PCR Technologies Market Analysis , 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for PCR providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.??????

For more informative information, please visit us – ?https://univdatos.com/report/pcr-technologies-market/

Market Segmentation:

1.?????By Product (Reagents & Consumables, Instruments, and Software)

2.?????By Technology (Real-Time PCR, Traditional PCR, and Digital PCR)

3.?????By Application (Clinical Diagnostics, Research, and Forensic)

4.?????By End-Users (Pharma & Biotechnology Companies, Diagnostics Labs & Hospitals, Academic & Government Research Institutes, and Others)

5.?????By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.?????By Company (Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, Takara Bio, Inc., Merck KGaA, BioMerieux SA, Siemens Healthineers, Abbott Laboratories, etc.)

Key questions answered in the study:

1.?????What are the current and future trends of the Global PCR technologies industry?

2.?????How the industry has been evolving in terms of end-user demand, application and technology areas?

3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.?????What are the key growth drivers and challenges for the PCR technologies industry?

5.?????What are the customer orientation, purchase behavior, and expectations from the PCR technologies firms across various regions??